Marshall Wace North America’s Urovant Sciences Ltd. UROV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-47,523
| Closed | -$766K | – | 1915 |
|
|
2020
Q4 | $766K | Buy |
47,523
+4,977
| +12% | +$80.2K | ﹤0.01% | 997 |
|
|
2020
Q3 | $397K | Buy |
42,546
+27,001
| +174% | +$252K | ﹤0.01% | 1015 |
|
|
2020
Q2 | $153K | Hold |
15,545
| – | – | ﹤0.01% | 1087 |
|
|
2020
Q1 | $143K | Buy |
+15,545
| New | +$143K | ﹤0.01% | 950 |
|
|
2019
Q4 | – | Sell |
-2,567
| Closed | -$24K | – | 1735 |
|
|
2019
Q3 | $24K | Buy |
+2,567
| New | +$24K | ﹤0.01% | 1222 |
|
|
2019
Q2 | – | Sell |
-4,902
| Closed | -$49K | – | 1809 |
|
|
2019
Q1 | $49K | Buy |
+4,902
| New | +$49K | ﹤0.01% | 1266 |
|